Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study

Maarten J Wensink, Ying Lu, Lu Tian, Gary M Shaw, Silvia Rizzi, Tina Kold Jensen, Elisabeth R Mathiesen, Niels E Skakkebæk, Rune Lindahl-Jacobsen, Michael L Eisenberg

37 Citationer (Scopus)

Abstract

Background: Diabetes reduces semen quality and increasingly occurs during reproductive years. Diabetes medications, such as metformin, have glucose-independent effects on the male reproductive system. Associations with birth defects in offspring are unknown. Objective: To evaluate whether the risk for birth defects in offspring varies with preconceptional pharmacologic treatment of fathers with diabetes. Design: Nationwide prospective registry-based cohort study. Setting: Denmark from 1997 to 2016. Participants: All liveborn singletons from mothers without histories of diabetes or essential hypertension. Measurements: Offspring were considered exposed if their father filled 1 or more prescriptions for a diabetes drug during the development of fertilizing sperm. Sex and frequencies of major birth defects were compared across drugs, times of exposure, and siblings. Results: Of 1 116 779 offspring included, 3.3% had 1 or more major birth defects (reference). Insulin-exposed offspring (n = 5298) had the reference birth defect frequency (adjusted odds ratio [aOR], 0.98 [95% CI, 0.85 to 1.14]). Metformin-exposed offspring (n = 1451) had an elevated birth defect frequency (aOR, 1.40 [CI, 1.08 to 1.82]). For sulfonylurea-exposed offspring (n = 647), the aOR was 1.34 (CI, 0.94 to 1.92). Offspring whose fathers filled a metformin prescription in the year before (n = 1751) or after (n = 2484) sperm development had reference birth defect frequencies (aORs, 0.88 [CI, 0.59 to 1.31] and 0.92 [CI, 0.68 to 1.26], respectively), as did unexposed siblings of exposed offspring (3.2%; exposed vs. unexposed OR, 1.54 [CI, 0.94 to 2.53]). Among metformin-exposed offspring, genital birth defects, all in boys, were more common (aOR, 3.39 [CI, 1.82 to 6.30]), while the proportion of male offspring was lower (49.4% vs. 51.4%, P = 0.073). Limitation: Information on underlying disease status was limited. Conclusion: Preconception paternal metformin treatment is associated with major birth defects, particularly genital birth defects in boys. Further research should replicate these findings and clarify the causation.

OriginalsprogEngelsk
TidsskriftAnnals of Internal Medicine
Vol/bind175
Udgave nummer5
Sider (fra-til)665-673
Antal sider9
ISSN0003-4819
DOI
StatusUdgivet - maj 2022

Fingeraftryk

Dyk ned i forskningsemnerne om 'Preconception Antidiabetic Drugs in Men and Birth Defects in Offspring: A Nationwide Cohort Study'. Sammen danner de et unikt fingeraftryk.

Citationsformater